319
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Radiation Stability of Sorbents in Medical 225Ac/213Bi Generators

ORCID Icon, , &

References

  • Marcu, L.; Bezak, E.; Allen, B. J. Global Comparison of Targeted Alpha Vs Targeted Beta Therapy for Cancer: In Vitro, in Vivo and Clinical Trials. Crit. Rev. Oncol. Hematol. 2018, 123, 7–20. DOI: 10.1016/j.critrevonc.2018.01.001.
  • Morgenstern, A.; Apostolidis, C.; Bruchertseifer, F. Supply and Clinical Application of Actinium-225 and Bismuth-213. Semin. Nucl. Med. 2020, 50(2), 119–123. DOI: 10.1053/j.semnuclmed.2020.02.003.
  • Sathekge, M.; Bruchertseifer, F.; Knoesen, O.; Reyneke, F.; Lawal, I.; Lengana, T.; Davis, C.; Mahapane, J.; Corbett, C.; Vorster, M.; et al. 225Ac-PSMA-617 in Chemotherapy-naive Patients with Advanced Prostate Cancer: A Pilot Study. Eur. J. Nucl. Med. Mol. Imaging. 2019, 46, 129–138. DOI: 10.1007/s00259-019-04401-9.
  • Sathekge, M.; Bruchertseifer, F.; Vorster, M.; Lawal, I. O.; Knoesen, O.; Mahapane, J.; Davis, C.; Reyneke, F.; Maes, A.; Kratochwi, C.; et al. Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy. J. Nucl. Med. 2020, 61(1), 62–69. DOI: 10.2967/jnumed.119.229229.
  • Atallah, E.; Berger, M.; Jurcic, J.; Roboz, G.; Tse, W.; Mawad, R.; Rizzieri, D.; Begna, K.; Orozco, J.; Craig, M.; et al. A Phase 2 Study of Actinium-225 (225ac)-lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML). J. Med. Imaging Radiat. Oncol. 2019, 50(1), S37. DOI: 10.1016/j.jmir.2019.03.113.
  • Merlo, A.; Krolicki, L.; Cordier, D.; Bruchertseifer, F.; Morgenstern, A. Improved Tumor Control and Absence of Late Neurotoxicity Using Alpha (213bi) as Compared to Beta (90Y) labelled-DOTA-Substance P for the Treatment of Low-Grade Gliomas. J. Med. Imaging Radiat. Oncol. 2019, 50(1), S37. DOI: 10.1016/j.jmir.2019.03.114.
  • Kratochwil, C.; Bruchertseifer, F.; Giesel, F.; Apostolidis, C.; Haberkorn, U.; Morgenstern, A. Ac-225-DOTATOC – An Empiric Dose Finding for Alpha Particle Emitter Based Radionuclide Therapy of Neuroendocrine Tumors. J. Nucl. Med. 2015, 56(S3), 1232.
  • Allen, B. J. A Comparative Evaluation of Ac-225 Vs Bi-213 as Therapeutic Radioisotopes for Targeted Alpha Therapy for Cancer. Australas. Phys. Eng. Sci. Med. 2017, 40(2), 369–376. DOI: 10.1007/s13246-017-0534-6.
  • Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; et al. Sequential Cytarabine and Alpha-particle Immunotherapy with Bismuth-213-lintuzumab (Hum195) for Acute Myeloid Leukemia. Clin. Cancer Res. 2010, 16, 5303–5311. DOI: 10.1158/1078-0432.CCR-10-0382.
  • Schmidt, D.; Neumann, F.; Antke, C.; Apostolidis, C.; Martin, S.; Morgenstern, A.; Molinet, R.; Heeger, S.; Kronenwett, R.; Muller, H. W.; et al. Phase I Clinical Study on Alpha Therapy for non-Hodgkin Lymphoma. In Proceedings of the 4th Alpha-immunotherapy Symposium, ITU, Dusseldorf, Germany, 2004, Morgenstern, A., Ed.; ITU: Germany, 2004; p 12.
  • Autenrieth, M. E.; Seidl, C.; Bruchertseifer, F.; Horn, T.; Kurtz, F.; Feuerecker, B.; D’Alessandria, C.; Pfob, C.; Nekolla, S.; Apostolidis, C.; et al. Treatment of Carcinoma in Situ of the Urinary Bladder with an Alpha-emitter Immunoconjugate Targeting the Epidermal Growth Factor Receptor: A Pilot Study. Eur. J. Nucl. Med. Mol. Imaging. 2018, 45, 1364–1371. DOI: 10.1007/s00259-018-4003-6.
  • Kratochwil, C.; Giesel, F. L.; Bruchertseifer, F.; Mier, W.; Apostolidis, C.; Boll, R.; Murphy, K.; Haberkorn, U.; Morgenstern, A. Bi-DOTATOC Receptor- Targeted Alpha-radionuclide Therapy Induces Remission in Neuroendocrine Tumours Refractory to Beta Radiation: A First-in-human Experience. Eur. J. Nucl. Med. Mol. Imaging. 2014, 41, 2106–2119. DOI: 10.1007/s00259-014-2857-9.
  • Krolicki, L.; Bruchertseifer, F.; Kunikowska, J.; Koziara, H.; Królicki, B.; Jakuciński, M.; Pawlak, D.; Apostolidis, C.; Mirzadeh, S.; Rola, R.; et al. Safety and Efficacy of Targeted Alpha Therapy with 213Bi-DOTA-substance P in Recurrent Glioblastoma. Eur. J. Nucl. Med. Mol. Imaging. 2019, 46, 614–622. DOI: 10.1007/s00259-018-4225-7.
  • Zhuikov, B. L.; Kalmykov, S. N.; Ermolaev, S. V.; Aliev, R. A.; Kokhanyuk, V. M.; Matushko, V. L.; Tananaev, I. G.; Myasoedov, B. F. Production of 225Ac and 223Ra by Irradiation of Th with Accelerated Protons. Radiochem. 2011, 53(1), 73–80. DOI: 10.1134/S1066362211010103.
  • Ermolaev, S. V.; Zhuikov, B. L.; Kokhanyuk, V. M.; Matushko, V. L.; Kalmykov, S. N.; Aliev, R. A.; Tananaev, I. G.; Myasoedov, B. F. Production of Actinium, Thorium and Radium Isotopes from Natural Thorium Irradiated with Protons up to 141 MeV. Radiochim. Acta. 2012, 100(4), 223–229. DOI: 10.1524/ract.2012.1909.
  • Apostolidis, C.; Molinet, R.; McGinley, J.; Abbas, K.; Möllenbeck, J.; Morgenstern, A. Cyclotron Production of Ac-225 for Targeted Alpha Therapy. Appl. Radiat. Isot. 2005, 62, 383–387. DOI: 10.1016/j.apradiso.2004.06.013.
  • Aliev, R. A.; Ermolaev, S. V.; Vasiliev, A. N.; Ostapenko, V. S.; Lapshina, E. V.; Zhuikov, B. L.; Zakharov, N. V.; Pozdeev, V. V.; Kokhanyuk, V. M.; Myasoedov, B. F.; et al. Isolation of Medicine-applicable Actinium-225 from Thorium Targets Irradiated by Medium-energy Protons. Solvent Extr. Ion Exch. 2014, 32(5), 468. DOI: 10.1080/07366299.2014.896582.
  • Zhuikov, B. L. Production of Medical Radionuclides in Russia: Status and Future—a Review. Appl. Radiat. Isot. 2014, 84, 48–56. DOI: 10.1016/j.apradiso.2013.11.025.
  • Hoehr, C.; Bénard, F.; Buckley, K.; Crawford, J.; Gottberg, A.; Hanemaayer, V.; Kunz, P.; Ladouceur, K.; Radchenko, V.; Ramogida, C.; et al. Medical Isotope Production at TRIUMF – From Imaging to Treatment. Phys. Procedia. 2017, 90, 200–208. DOI: 10.1016/j.phpro.2017.09.059.
  • John, K. US DOE Tri-lab Research and Production Effort to Provide Accelerator- Produced 225Ac for Radiotherapy: 2019 Update. Eur. J. Nucl. Med. Mol. Imaging. 2019, 46, S722. DOI: 10.1016/j.jmir.2019.11.009.
  • Morgenstern, A.; Apostolidis, C.; Kratochwil, C.; Sathekge, M.; Krolicki, L.; Bruchertseifer, F. An Overview of Targeted Alpha Therapy with 225actinium and 213bismuth. Curr. Radiopharm. 2018, 11(3), 200–208. DOI: 10.2174/1874471011666180502104524.
  • Institute for Transuranium Elements. Production of 225Ac/213Bi for Targeted Alpha Therapy; Annual report 2006; Office for Official Publications of the European Communities: Luxembourg, 2007.
  • Brookhaven National Laboratory. National Nuclear Data Center. http://www.nndc.bnl.gov/nudat2/ ( accessed April 04, 2020).
  • Ermolaev, S. V.; Skasyrskaya, A. K. Razrabotka Tsirkuliruyushchey Skhemy Polucheniya 213Bi Iz 221Fr, Nepreryvno Otdelyaemogo Ot 225Ac. In Book of Abstracts. Proceedings of the IX Russian Conference “Radiochemistry 2018”, Saint-Petersburg, Sept. 17–21, 2018; Myasoedov, B. F., Kalmykov, S. N., Petrov, V. G., Eds.; Rosatom: Saint-Petersburg, 2018; p 495.
  • Voyles, A. S.; Bernstein, L. A.; Birnbaum, E. R.; Engle, J. W.; Graves, S. A.; Kawano, T.; Lewis, A. M.; Nortier, F. M. Excitation Functions for (P, X) Reactions of Niobium in the Energy Range of Ep = 40–90 MeV. Nucl. Instrum. Methods Phys. Res. B. 2018, 429, 53–74. DOI: 10.1016/j.nimb.2018.05.028.
  • Caletka, R.; Krivan, V. A Group Separation Based on Anion- and Cation-exchange from Hydrofluoric Acid Medium: Application to Multielement Neutron-activation Analysis of Niobium. Talanta. 1983, 30(7), 465–470. DOI: 10.1016/0039-9140(83)80111-8.
  • Bystrov, P. A.; Pavlov, Y. S.; Souvorova, O. V.; Yakupov, I. Y. Formation of Irradiation Beams on Accelerator UELV-10-10-С-70 for Research of Radiation Resistance of Polymers. Radiat. Phys. Chem. 2019, 161, 83–86. DOI: 10.1016/j.radphyschem.2019.03.053.
  • Abdulov, R. A.; Abramov, V. N.; Generalova, V. V.; Gursky, M. N.; Zhanzhora, A. P.; Meshcheryakova, N. K.; Yakovlev, V. B. Color Visual Indicator of the Absorbed Dose of Ionizing Radiation and the Method of Its Manufacture. Russian patent 2,225,625, February 11, 2002.
  • Horwitz, E. P.; Chiarizia, R.; Dietz, M. L. DIPEX: A New Extraction Chromatographic Material for the Separation and Preconcentration of Actinides from Aqueous Solution. React. Funct. Polym. 1997, 33(1), 25–36. DOI: 10.1016/S1381-5148(97)00013-8.
  • Horwitz, E. P.; Dietz, M.; Chiarizia, R.; Diamond, H.; Essling, A. M.; Graczyk, D. Separation and Preconcentration of Uranium from Acidic Media by Extraction Chromatography. Anal. Chim. Acta. 1992, 266, 25–37. DOI: 10.1016/0003-2670(92)85276-C.
  • Schauer, D. A.; Brodsky, A.; Sayeg, J. A. Radiation Dosimetry. In Handbook of Radioactivity Analysis, 2nd ed.; L’Annunziata, M. F., Ed.; Elsevier: USA, 2003; pp 1165–1208.
  • Chmielewski, A. G.; Szołucha, M. M. Radiation Chemistry for Modern Nuclear Energy Development. Radiat. Phys. Chem. 2016, 124, 235–240. DOI: 10.1016/j.radphyschem.2016.01.002.
  • Mincher, B. J.; Modolo, G.; Mezyk, S. P. Review Article: The Effects of Radiation Chemistry on Solvent Extraction 3: A Review of Actinide and Lanthanide Extraction. Solvent Extr. Ion Exch. 2009, 27, 579–606. DOI: 10.1080/07366290903114098.
  • Morgenstern, A.; Bruchertseifer, F.; Apostolidis, C. Bismuth-213 and Actinium-225–generator Performance and Evolving Therapeutic Applications of Two Generator-derived Alpha-emitting Radioisotopes. Curr. Radiopharm. 2012, 5(3), 221–227. DOI: 10.2174/1874471011205030221.
  • Boll, R. A.; Mirzadeh, S.; Kennel, S. J. Optimizations of Radiolabeling of Immunoproteins with 213Bi. Radiochim. Acta. 1997, 79(2), 145–150. DOI: 10.1524/ract.1997.79.2.145.
  • McDevitt, M. R.; Finn, R. D.; Sgouros, G.; Ma, D.; Scheinberg, D. A. An 225Ac/213Bi Generator System for Therapeutic Clinical Applications: Construction and Operation. Appl. Radiat. Isot. 1999, 50, 895–904. DOI: 10.1016/S0969-8043(98)00151-1.
  • Ma, D.; McDevitt, M. R.; Finn, R. D.; Scheinberg, D. A. Breakthrough of 225Ac and Its Radionuclide Daughters from an 225Ac/213Bi Generator: Development of New Methods, Quantitative Characterization, and Implications for Clinical Use. Appl. Radiat. Isot. 2001, 55(5), 667–678. DOI: 10.1016/S0969-8043(01)00062-8.
  • Ma, D.; McDevitt, M. R.; Finn, R. D.; Scheinberg, D. A. Rapid Preparation of Short-lived Alpha Particle Emitting Radioimmunopharmaceuticals. Appl. Radiat. Isot. 2001, 55(4), 463–470. DOI: 10.1016/S0969-8043(01)00048-3.
  • Gangwer, T. E.; Goldstein, M.; Pillay, K. K. S. Radiation Effects on Ion Exchange Materials (No. BNL-50781). Brookhaven National Lab.: Upton, NY, USA, 1977.
  • Kazanjian, A. R.; Killion, M. E. Radiation Effects on Amberlite IRA-938 and Bio-rad AG MP-50 Ion Exchange Resins. [Gamma Radiation] (No. RFP-3167). Rockwell International Corp., Rocky Flats Plant.: Golden, CO, USA, 1982.
  • Kazanjian, A. R.; Horrell, D. R. Radiation Effects on Ion Exchange Resins. I. Gamma Irradiation of Dowex 50W (No. RFP-2140). Dow Chemical USA, Rocky Flats Div., Golden, Colo, USA, 1974.
  • Kazanjian, A. R.; Horrell, D. R. Radiation Effects on Ion Exchange Resins. III. Alpha Irradiation of Dowex 50W (No. RFP-2298). Dow Chemical USA, Rocky Flats Div., Golden, Colo, USA, 1975.
  • Kiseleva, E. D.; Chmutov, K. V.; Krupnova, V. N. Effect of Accelerated Electrons on KU-2 Cation Exchange resin—I. Russ. J. Phys. Chem. 1961, 35(8), 892.
  • Guseva, L.; Dogadkin, N. A Generator System for Production of Medical Alpha-radionuclides Ac-225 and Bi-213. J. Radioanal. Nucl. Chem. 2010, 285(3), 667–673. DOI: 10.1007/s10967-010-0593-6.
  • Moore, M. A.; Counce, R. M.; Watson, J. S.; Hall, H. The Performance of Two Silica-based Ion Exchange Resins in the Separation of 213Bi from Its Parent Solution of 225Ac. Appl. Radiat. Isot. 2018, 141, 68–72. DOI: 10.1016/j.apradiso.2018.08.020.
  • Wu, C.; Brechbiel, M. W.; Gansow, O. A. An Improved Generator for the Production of 213Bi from 225Ac. Radiochim. Acta. 1997, 79, 141–144. DOI: 10.1524/ract.1997.79.2.141.
  • Dietz, M. L.; Horwitz, E. P. Applications of Extraction Chromatography in the Development of Radionuclide Generator Systems for Nuclear Medicine. Ind. Eng. Chem. Res. 2000, 39(9), 3181–3188. DOI: 10.1016/j.apradiso.2018.08.020.
  • Sinenko, I. L.; Kalmykova, T. P.; Likhosherstova, D. V.; Egorova, B. V.; Zubenko, A. D.; Vasiliev, A. N.; Ermolaev, S. V.; Lapshina, E. V.; Ostapenko, V. S.; Fedorova, O. A.; et al. 213Bi Production and Complexation with New Picolinate Containing Ligands. J. Radioanal. Nucl. Chem. 2019, 321(2), 531–540. DOI: 10.1007/s10967-019-06610-w.
  • Chiarizia, R.; Horwitz, E. P. Radiolytic Stability of Some Recently Developed Ion Exchange and Extraction Chromatographic Resins Containing Diphosphonic Acid Groups. Solvent Extr. Ion Exch. 2000, 18(1), 109–132. DOI: 10.1080/07366290008934675.
  • Shu, Q.; Khayambashi, A.; Wang, X.; Wang, X.; Feng, L.; Wei, Y. Effects of γ Irradiation on Bis (2-ethylhexyl) Phosphoric Acid Supported by Macroporous Silica-based Polymeric Resins. Radiochim. Acta. 2018, 106(3), 249–258. DOI: 10.1515/ract-2017-2758.
  • Zhang, A.; Wei, Y.; Hoshi, H.; Kumagai, M.; Kamiya, M.; Koyama, T. Resistance Properties of a Macroporous Silica-based N, N, N′, N′-tetraoctyl-3-oxapentane-1, 5-diamide-impregnated Polymeric Adsorption Material against Nitric Acid, Temperature and γ-irradiation. Radiat. Phys. Chem. 2005, 72(6), 669–678. DOI: 10.1016/j.radphyschem.2004.05.050.
  • McAlister, D. R.; Horwitz, E. P. Automated Two Column Generator Systems for Medical Radionuclides. Appl. Radiat. Isot. 2009, 67, 1985–1991. DOI: 10.1016/j.apradiso.2009.07.019.
  • Bray, L. A.; Tingey, J. M.; DesChane, J. R.; Egorov, O. B.; Tenforde, T. S.; Wilbur, D. S.; Hamlin, D. K.; Pathare, P. M. Development of a Unique Bismuth (Bi-213) Automated Generator for Use in Cancer Therapy. Ind. Eng. Chem. Res. 2000, 39, 3189–3194. DOI: 10.1021/ie990068r.
  • Betenekov, N. D.; Denisov, E. I.; Vasiliev, A. N.; Ermolaev, S. V.; Zhuikov, B. L. Perspectives for Ac-225/Bi-213 Generator Developing Using Hydroxide Inorganic Sorbents. Radiochem. 2019, 61(2), 211–219. DOI: 10.1134/S1066362219020140.
  • Vasiliev, A. N.; Ermolaev, S. V.; Lapshina, E. V.; Zhuikov, B. L.; Betenekov, N. D. 225Ac/213Bi Generator Based on Inorganic Sorbents. Radiochim. Acta. 2019, 107(12), 1203–1211. DOI: 10.1515/ract-2019-3137.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.